Literature DB >> 18155131

RNA-binding protein Dnd1 inhibits microRNA access to target mRNA.

Martijn Kedde1, Markus J Strasser, Bijan Boldajipour, Joachim A F Oude Vrielink, Krasimir Slanchev, Carlos le Sage, Remco Nagel, P Mathijs Voorhoeve, Josyanne van Duijse, Ulf Andersson Ørom, Anders H Lund, Anastassis Perrakis, Erez Raz, Reuven Agami.   

Abstract

MicroRNAs (miRNAs) are inhibitors of gene expression capable of controlling processes in normal development and cancer. In mammals, miRNAs use a seed sequence of 6-8 nucleotides (nt) to associate with 3' untranslated regions (3'UTRs) of mRNAs and inhibit their expression. Intriguingly, occasionally not only the miRNA-targeting site but also sequences in its vicinity are highly conserved throughout evolution. We therefore hypothesized that conserved regions in mRNAs may serve as docking platforms for modulators of miRNA activity. Here we demonstrate that the expression of dead end 1 (Dnd1), an evolutionary conserved RNA-binding protein (RBP), counteracts the function of several miRNAs in human cells and in primordial germ cells of zebrafish by binding mRNAs and prohibiting miRNAs from associating with their target sites. These effects of Dnd1 are mediated through uridine-rich regions present in the miRNA-targeted mRNAs. Thus, our data unravel a novel role of Dnd1 in protecting certain mRNAs from miRNA-mediated repression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18155131     DOI: 10.1016/j.cell.2007.11.034

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  321 in total

Review 1.  microRNAs, the cell's Nepenthe: clearing the past during the maternal-to-zygotic transition and cellular reprogramming.

Authors:  Antonio J Giraldez
Journal:  Curr Opin Genet Dev       Date:  2010-05-06       Impact factor: 5.578

Review 2.  From microRNAs to targets: pathway discovery in cell fate transitions.

Authors:  Deepa Subramanyam; Robert Blelloch
Journal:  Curr Opin Genet Dev       Date:  2011-06-01       Impact factor: 5.578

3.  Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.

Authors:  Han Qin; Kathryn Blaschke; Grace Wei; Yuki Ohi; Laure Blouin; Zhongxia Qi; Jingwei Yu; Ru-Fang Yeh; Matthias Hebrok; Miguel Ramalho-Santos
Journal:  Hum Mol Genet       Date:  2012-01-27       Impact factor: 6.150

Review 4.  MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship.

Authors:  Amy E Pasquinelli
Journal:  Nat Rev Genet       Date:  2012-03-13       Impact factor: 53.242

5.  The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells.

Authors:  Michael R Epis; Andrew Barker; Keith M Giles; Dianne J Beveridge; Peter J Leedman
Journal:  J Biol Chem       Date:  2011-10-04       Impact factor: 5.157

Review 6.  The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC.

Authors:  Marc R Fabian; Nahum Sonenberg
Journal:  Nat Struct Mol Biol       Date:  2012-06-05       Impact factor: 15.369

7.  Elr-type proteins protect Xenopus Dead end mRNA from miR-18-mediated clearance in the soma.

Authors:  Katja Koebernick; Jana Loeber; Patrick Kobina Arthur; Katsiaryna Tarbashevich; Tomas Pieler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

Review 8.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

9.  Ancestral paternal genotype controls body weight and food intake for multiple generations.

Authors:  Soha N Yazbek; Sabrina H Spiezio; Joseph H Nadeau; David A Buchner
Journal:  Hum Mol Genet       Date:  2010-08-09       Impact factor: 6.150

10.  Affinity purification of microRNA-133a with the cardiac transcription factor, Hand2.

Authors:  Ngan K Vo; Ryan P Dalton; Ning Liu; Eric N Olson; Richard H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.